Psychiatric disorders during pregnancy

References

• ADDIS, A. & KOREN, G. (2000). Safety of fluoxetine during the first trimester of pregnancy: a meta-analytical review of epidemiological studies. Psychological Medicine, 30, 89–94
   PubMed Web of Science ®Google Scholar
• ALLISTER, L., LESTER, B.M., CARR, S. & Liu, J. (2001). The effects of maternal depression on fetal heart rate response to vibroacoustic stimulation. Developmental Neuropsychology, 20(3), 639–651
   PubMed Web of Science ®Google Scholar
• ALTSHULER, L., COHEN, L., SZUBA, M.P., BURT, V.K., GITLIN, M. & MINTZ, J. (1996). Pharmacologic manage-ment of psychiatric illness during pregnancy: dilemmas and guidelines. American journal of Psychiatry, 153, 592–606
   PubMed Web of Science ®Google Scholar
• ALTSHULER, L.L. & HENDIUCK, V. (1996). Pregnancy and psychotropic medication: changes in blood levels. Journal of Clinical Psychopharmacology, 16, 78–80
   PubMed Web of Science ®Google Scholar
• ALTSHULER, L.L., HENDRICK, V. & COHEN, L.S. (1998). Course of mood and anxiety disorders during pregnancy and the postpartum period. Journal of Clinical Psychiatry, 59\(Suppl. 2), 29–33
   PubMedGoogle Scholar
• AMERICAN MEDICAL ASSOCIATION (1983). Drug interactions and adverse drug interactions. In: ANIA Drug Evaluations ( pp. 31–44). Chicago: American Medical Association
   Google Scholar
• APPLEBY, L. (1991). Suicide during pregnancy and in the first postnatal year. British Medical Journal, 302, 137–140
   PubMed Web of Science ®Google Scholar
• AUERBACH, J.G., HANs, S.L., MARCUS, J., & MAEIR, S. (1992). Maternal psychotropic medication and neonatal behavior. Neurotoxicology & Teratology, 14, 399–406
   PubMed Web of Science ®Google Scholar
• BALDESSARINI, R.J., TONDO, L. & VIGUERA, A.C. (1999). Effects of discontinuing lithium maintenance treatment. Bipolar Disorders, 1, 17–24
   PubMedGoogle Scholar
• BARLOW, S.M., KNIGHT, A.F. & SULLIVAN, F.M. (1979). Prevention by diazepam of adverse effects of maternal restraint stress on postnatal development and learning in the rat. Teratology, 19, 105–110
   PubMedGoogle Scholar
• BENNEDSEN, B.E. (1998). Adverse pregnancy outcome in schizophrenic women: occurrence and risk factors. Schizophrenia Research, 33, 1–26
   PubMed Web of Science ®Google Scholar
• BENNEDSEN, B.E., MORTENSEN, P.B., OLESEN, A.V., HENRIKSEN, T.B. & FRYDENBERG, M. (2001). Obstetric complications in women with schizophrenia. Schizophrenia Research, 47, 167–175
   PubMed Web of Science ®Google Scholar
• BIRNDORF, C.A., MADDEN, A., PORTERA, L. & LEON, A.C. (2001). Psychiatric symptoms, functional impairment, and receptivity toward mental health treatment among obstetrical patients. International journal of Psychiatry & Medicine, 31, 355–365
   PubMed Web of Science ®Google Scholar
• BLEHAR, M, DEPAULO, J., GERSHON, E., REICH, T., SIMPSON, S.G. & NURNBERGER, J.I., JR. (1988). Women with bipolar disorder: findings from the NIMH genetics initiative sample. Psychopharmacological Bulletin, 34, 239–243
   Google Scholar
• BOGARDUS, S., HOLMBOE, E. & JEKEL, J.F. (1999). Perils, pitfalls, and possibilities in talking about medical risk. Journal of the American Medical Association, 281, 1037–1041
   PubMed Web of Science ®Google Scholar
• BROCKINGTON, I.F., OATES, M. & ROSE, G. (1990). Prepartum psychosis. Journal of Affective Disorders, 19, 31–35
   PubMed Web of Science ®Google Scholar
• BROUGHER, J.C. (1960). Use of an anti-emetic agent in nausea and vomiting associated with pregnancy. Western Medicine, I, 9
   Google Scholar
• BURKE, K.C., BURKE, J.D., RAE, D.S. & REGIER, D.A. (1991). Comparing age at onset of major depression and other psychiatric disorders by birth cohorts in five US community populations. Archive in General Psychiatry, 48, 789–795
   PubMed Web of Science ®Google Scholar
• CHAMBERS, C.D., JOHNSON, K.A., DICK, L.N., FELIX, R.J. & JONES, K.L. (1996). Birth outcomes in pregnant women taking fluoxetine. New England Journal of Medicine, 335, 1010–1015
   PubMed Web of Science ®Google Scholar
• CHAMBLESS, D.L. & Gmus, M.M. (1993). Cognitive therapy of anxiety disorders. Journal of Consulting and Clinical Psychology, 61, 248–260
   PubMed Web of Science ®Google Scholar
• CHELMOW, D. & HALFIN, V.P. (1997). Pregnancy compli-cated by obsessive-compulsive disorder. Journal of Maternal-Fetal Medicine, 6, 31–34
   PubMedGoogle Scholar
• CHIU, C.C., HUANG, S.Y., SHEN, W. & Su, K.P. (2003). Omega-3 fatty acids for depression in pregnancy. American Journal of Psychiatry, 160, 385
   PubMed Web of Science ®Google Scholar
• CHUNG, T.K., LAU, T.K., YIP, A.S., CHiu, H.F. & TFF, D.T. (2001). Antepartum depressive symptomatology is associated with adverse obstetric and neonatal out-comes. Psychosomatic Medicine, 63(5), 830–834
   PubMed Web of Science ®Google Scholar
• CLAES, M., Ms, M. & JACQUEMYN, Y. (1997). The contribution of biological factors to the pathogenesis of psychiatric disorders in the postpartum period: a survey. Acta Neuropsychiatrica, 9,128–132
   PubMed Web of Science ®Google Scholar
• COHEN, L.S., HELLER, V.L., BAILEY, J.W., GRUSH, L., ABLON, J.S. & BOUFFARD, S.M. (2000). Birth outcomes following prenatal exposure to fluoxetine. Biological Psychiatry, 48, 996–1000
   PubMed Web of Science ®Google Scholar
• COHEN, L.S., FRIEDMAN, J.M., JEFFERSON, J.W., JOHNSON, E.M. & WEINER, M.L. (1994). A re-evaluation of the risk of in utero exposure to lithium. Journal of the American Medical Association, 271, 146–150
   PubMed Web of Science ®Google Scholar
• COHEN, L.S. & ROSENBAUM, J.F. (1998). Psychotropic drug use during pregnancy: weighing the risks. Journal of Clinical Psychiatry, 59\(Suppl. 2), 18–28
   PubMedGoogle Scholar
• COHEN, L.S., ROSENBAUM, J.F. & HELLER, V.L. (1989). Panic attack-associated placental abruption: a case report. Journal of Clinical Psychiatry, 50, 266–267
   PubMed Web of Science ®Google Scholar
• COHEN, L.S., SICHEL, D.A., FARAONE, S.V., ROBERTSON, L.M., DimmocK, J.A. & ROSENBAUM, J.F. (1996). Course of panic disorder during pregnancy and the puerperium: a preliminary study. Biological Psychiatry, 39,950–954
   PubMed Web of Science ®Google Scholar
• COHEN, L.S., SICHEL, D.A., ROBERTSON, L.M., HECKSCHER, E. & ROSENBAUM, J.F.(1995). Post-partum prophylaxis for women with bipolar disorder. American Journal of Psychiatry, 152, 1641–1645
   Google Scholar
• COSTEI, A.M., KOZER, E., Ho, T., ITO, S. & KOREN, G. (2002). Perinatal outcome following third trimester exposure to paroxetine. Archives of Pediatric & Adolescent Medicine, 156, 1129–1132
   PubMed Web of Science ®Google Scholar
• COTT, J. (2000). Omega-3 fatty acids and pregnancy. Alternative Therapies in Women‘s Health, 2(12), 89–92
   Google Scholar
• COVERDALE, J.H., MCCULLOUGH, L.B. & CHERVENAK, F.A. (2002). Enhancing decision-making by depressed pregnant patients. Journal of Perinatal Medicine, 30(4), 349–351
   PubMed Web of Science ®Google Scholar
• COWE, L., LLOYD, D.J. & DAWLING, S. (1982). Neonatal convulsions caused by withdrawal from maternal clomipramine. British Medical Journal, 284, 1837–1838
   PubMed Web of Science ®Google Scholar
• DAYAN, J., CREVEUIL, C., HERLICOVIEZ, M., HERBEL, C., BARANGER, E., SAVOYE, C. & THoulx, A. (2002). Role of anxiety and depression in the onset of spontaneous preterm labor. American Journal of Epidemiology, 155(4), 293–301
   PubMed Web of Science ®Google Scholar
• DEBER, R.B., KRAETSCHMER, N. & IRVINE, J. (1996). What role do patients wish to play in decision-making? Archives in Internal Medicine, 156, 1414–1420
   Google Scholar
• DELGADO-ESCUETA, A.V. & JANz, D. (1992). Consensus guidelines: preconception counseling, management, and care of the pregnant woman with epilepsy. Neurology, 42(Suppl. 5), 149–160
   PubMedGoogle Scholar
• DESMOND, M.M., RUDOLPH, A.J. & HILL, R.M. (1967). Behavioral alterations in infants born to mothers on psychoactive medication during pregnancy. In: G. FARRELL (Ed), Congenital Mental Retardation. Austin: University of Texas
   Google Scholar
• DICKSON, R.A. & HOGG, L. (1998). Pregnancy of a patient treated with clozapine. Psychiatric Services, 49, 1081–1083
   PubMed Web of Science ®Google Scholar
• DOLOVICH, L.R., ADDIS, A., VAILLANCOURT, J.M., POWER, J.D., KOREN, G. & EINARSON, T.R. (1998). Benzodiazepine use in pregnancy and major malforma-tions or oral cleft: meta-analysis of cohort and case-control studies. British Medical Journal, 317, 839–843
   PubMed Web of Science ®Google Scholar
• EINARSON, A., FATOYE, B., SARKAR, M., LAVIGNE, S.V., BROCHU, J., CHAMBERS, C., MASTROIACOV, P., ADDIS, A., MATSUI D., SCHULER, L., EINARSON, T.R. & KOREN, G. (2001). Pregnancy outcome following gestational expo-sure to venlafaxine: a multicenter prospective controlled study. American Journal of Psychiatry, 158, 1728–1730
   Google Scholar
• ERICSON, A., KALLEN, B. & Wu-1mm, B. (1999). Delivery outcome after the use of antidepressants in early pregnancy. European Journal of Clinical Pharmacology, 55,503–508
   Google Scholar
• ERNST, C.L. & GOLDBERG, J.F. (2002). The reproductive safety profile of mood stabilizers, atypical antipsychotics, and broad-spectrum psychotropics. Journal of Clinical Psychiatry, 63 (Suppl. 4), 42–55
   PubMedGoogle Scholar
• EVANS, J., HERON, J., FRANCOMB, H., OKE, S. & GOLDING, J. (2001). Cohort study of depressed mood during pregnancy and after childbirth. British Medical Journal, 323, 257–260
   PubMed Web of Science ®Google Scholar
• FDA (1999). Concept paper on pregnancy labeling. Summary of comments from a public hearing and model pregnancy labeling based on recommendations. May 20,1999. http://www.fda.gov/ohrms/dockets/ac/99/ transcpt/3516r1.doc
   Google Scholar
• FERRILL, M.J., KEHOE, W.A. & JAcisiN, J.J. (1992). ECT during pregnancy: physiologic and pharmacologic considerations. Convulsant Therapy, 8, 186–200
   PubMedGoogle Scholar
• FRANK, E., KUPFER, D . J., PEREL, J.M., CORNS, C., JARRETT, D.B., MALLINGER, A.G., THASE, M.E., MCEACHRAN, A.B. & GROCHOCHINSKI, V.J. (1990). Three-year outcomes for maintenance therapies in recurrent depression. Archives in General Psychiatry, 47, 1093–1099
   Google Scholar
• FREEMAN, M.P. (2000). Omega-3 fatty acids in psychiatry: a review. Annals in Clinical Psychiatry, 12, 159–165
   PubMedGoogle Scholar
• FREEMAN, M.P., WOSNITZER-SMITH, K., FREEMAN, S.A., MCELROY, S.L., KMETZ, G.F., WIUGHT, R. & KECK, P.E. JR. (2002). The impact of reproductive events on the course of bipolar disorder in women. Journal of Clinical Psychiatry, 63, 284–287
   PubMed Web of Science ®Google Scholar
• GEORGE, D.T., LADENHEIM, J.A. & NuTT, D.J. (1987). Effects of pregnancy on panic attacks. American Journal of Psychiatry, 144, 1078–1079
   PubMed Web of Science ®Google Scholar
• GOLDSTEIN, D.J., CORBIN, L.A. & FUNG, M.C. (2000). Olanzapine-exposed pregnancies and lactation: early experience. Journal of Clinical Psychopharmacology, 20, 399–403
   PubMed Web of Science ®Google Scholar
• GOTLIB, I.H., WHIFF1N, V.E., MOUNT, J.H., MILNE, K. & CORDY, N.I. (1989). Prevalence rates and demographic characteristics associated with depression in pregnancy and the postpartum. Journal of Consulting Clinical Psychology, 57, 269–274
   Google Scholar
• GRACIOUS, B.L. & WISNER, K.L. (1997). Phenelzine use throughout pregnancy and the puerperium: case report, review of the literature, and management recommenda-tions. Depression & Anxiety, 6, 124–128
   PubMedGoogle Scholar
• GRANSTROM, M.L. (1982). Development of the children of epileptic mothers-preliminary results from the prospective Helsinki study. In: D. JANz, L. Boss‘ & M. DAM et al., (Eds), Epilepsy, Pregnancy, and the Child (pp. 403–408). New York: Raven Press
   Google Scholar
• GROF, P., ROBBINS, W., ALDA, M., BERGHOEFER, A, VOJTECHOVSKY, M., NILSSON, A. & ROBERTSON, C. (2000). Protective effect of pregnancy in women with lithium-responsive bipolar disorder. Journal of Affective Disorders, 6/(1–2), 31–39
   Google Scholar
• GUAY, J., GRENIER, Y. & VARIN, F. (1998). Clinical pharmacokinetics of neuromuscular relaxants in pregnancy. Clinical Pharmacokinetics, 34, 483–496
   PubMed Web of Science ®Google Scholar
• HARTZ, S.C., HEINONEN, 0.P., SHAPIRO, S., SISKIND, V. & SLONE, D. (1975). Antenatal exposure to meprobamate and chlordiazepoxide in relation to malformations, mental development, and childhood mortality. New England journal of Medicine, 292, 726–728
   Google Scholar
• HEIKKINEN, T., EKBLAD, U., KERO, P., EKBLAD, S. & LAINE, K. (2002). Citalopram in pregnancy and lacta-tion. Clinical Pharmacology & Therapy, 72, 184–191
   PubMed Web of Science ®Google Scholar
• HEINONEN, 0.P., SLONE, D. & SHAPIRO, S. (1977). Birth defects and drugs in pregnancy. Littleton, Mass: Publishing Science Group
   Google Scholar
• HENDRICK, V. & ALTSHULER, L. (2002). Management of major depression during pregnancy. American Journal of Psychiatry, /59(10), 1667–1673
   Google Scholar
• HENDRICK, V.C. & ALTSHULER, L.L. (1997). Management of breakthrough panic disorder symptoms during pregnancy (letter). Journal of Clinical Psychopharma-cology, 17, 228–229
   Web of Science ®Google Scholar
• HIBBELN, J.R. (2002). Seafood consumption, the DHA content of mothers‘ milk and prevalence rates of postpartum depression: a cross-sectional, ecological analysis. Journal of Affective Disorders, 69, 15–29
   PubMed Web of Science ®Google Scholar
• HOLMES, L.B., HARVEY, E.A., Cow., B.A., HUNTINGDON, K.B., KHOSHBIN, S., HAYES, A.M. & RYAN, L.M. (2001). The teratogenicity of anticonvulsant drugs. New England Journal of Medicine, 334, 1132–1138
   Google Scholar
• HOSTETTER, A., STOWE, Z.N., STRADER, J.R. JR., MCLAUGHLIN, E. & LLEWFT T YN, A. (2000). Dose of selective serotonin uptake inhibitors across pregnancy: clinical implications. Depression & Anxiety, 11(2), 51–57
   Google Scholar
• HUTCHINGS, D.E. (1983). Behavioral teratology: a new frontier in neurobehavioral research. In: E.M. JOHNSON & D.M. KOCHHAR (Eds), Teratogenesis and Reproductive Toxicology (pp. 207–235). New York: Springer Verlag
   Google Scholar
• ISTVAN, J. (1986). Stress, anxiety, and birth outcomes: a critical review of the evidence. Psychological Bulletin, 100, 331–348
   PubMed Web of Science ®Google Scholar
• IQBAL, M.M., GUNDLAPALLI, S.P., RYAN, W.G., RYALS, T. & PASSMAN, T.E. (2001). Effects of anti-manic mood-stabilizing drugs on fetuses, neonates, and nursing infants. Southern Medicine Journal, 94, 304–322
   PubMed Web of Science ®Google Scholar
• JACOBSON, S.j, JONES, K., JOHNSON, K., CEOZIN, L., KAUR, P., SAHN, D., DONNENFELD, A.E., RIEDER, M., SANTELLI, R. & SmyTEE, J. (1992). Prospective multi-center study of pregnancy outcome after lithium exposure during first trimester. Lancet, 339, 530–533
   Google Scholar
• JoHANsoN, R., CHAPMAN, G., MURRAY, D., JOHNSON, I. & COX, J. (2000). The North Staffordshire Maternity Hospital prospective study of pregnancy-associated depression. Journal of Psychosomatic Obstetrics & Gynecology, 21(2), 93–97
   PubMed Web of Science ®Google Scholar
• KENDELL, R.E., CHALMERS, J.C. & PLATZ, C. (1987). Epidemiology of puerperal psychoses. British Journal of Psychiatry, 150, 662–673
   PubMed Web of Science ®Google Scholar
• KENT, L.S. & LAIDLAW, J.D. (1995). Suspected congenital sertraline dependence. British Journal of Psychiatry, 167, 412–413
   PubMed Web of Science ®Google Scholar
• KESSLER, R. C., MCGONAGLE, K.A., ZHAO, S., NELSON, C.B .3 HUGHES, M., ESHLEMAN, S., WITTCHEN, H.U. & KENDLER, K.S. (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Archives in General Psychiatry, 51, 8–19
   Google Scholar
• KOREN, G., BOLOGA, M., LONG, D., FELDMAN, Y. & SHEAR, N.H. (1989). Perception of teratogenic risk by pregnant women exposed to drugs and chemicals during the first trimester. American Journal of Obstetrics & Gynecology, 160, 1190–1194
   PubMed Web of Science ®Google Scholar
• KOREN, G., COHN, T., CHITAYAT, D., KAPUR, B., REMINGTON, G., REED, D.M. & ZIPURSKY, R.B. (2002). Use of atypical antipsychotics during pregnancy and the risk of neural tube defects in infants. American Journal of Psychiatry, 159, 136–137
   PubMed Web of Science ®Google Scholar
• KULIN, N.A., PASTUSZAK, A., SAGE, S.R., SCHICK-BOSCHETTO, B., SPIVEY, G., FELDKAMP, M., ORMOND, K., MATSUI, D., STEIN-SCHECHMAN, A.K., COOK, L., BROCHU, J., RIEDER, M. & KOREN, G. (1998). Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors. Journal of the American Medical Association, 279, 609–610
   PubMed Web of Science ®Google Scholar
• KURKI, T., FIIILESMAA3 V., RAITASALO, R., MATTILA, H. & YLIKORKALA, 0. (2000). Depression and anxiety in early pregnancy and risk for preeclampsia. Obstetrics & Gynecology, 95, 487–490
   Google Scholar
• LAEGREID, L., OLEGARD, R., CONRADI, N., HAGBERG, G., WAHLSTROM, J. & ABRAHAMSSON, L. (1990). Congenital malformations and maternal consumption of benzodia-zepines: a case control study. Developmental Medicine & Child Neurology, 32, 432–441
   PubMed Web of Science ®Google Scholar
• LAMOTRIGINE PREGNANCY REGISTRY. (2002). Interim report, September 1992 through March 2001. GlaxoSmith Kline Corporation, Research Triangle, NC
   Google Scholar
• LIER, L., KASTRUP, M. & RAFAELSEN, O.J. (1989). Psychiatric illness in relation to childbirth and preg-nancy, II: diagnostic profiles, psychosocial and perinatal aspects. Nordisk Psykiatrisk Tidsskrift, 43, 535–542
   Google Scholar
• LINDHOUT, D. & OMTZIGT, J.G.C. (1994). Teratogenic effects of anti-epileptic drugs: implications for the management of epilepsy in women of childbearing age. Epilepsia, 35, 519–528
   Web of Science ®Google Scholar
• LIVEZEY, G.T. & RAYBURN, W.F. (1992). Principles of perinatal pharmacology. In: W.F. RAYBURN & F.P. ZUSPAN (Eds), Drug Therapy in Obstetrics and Gynecology, 3rd edition. (pp. 3–12). St. Louis: Mosby Year Book Inc
   Google Scholar
• LLEWELLYN, A., STOWE, Z.N. & STRADER J.R. JR. (1998). The use of lithium and management of women with bipolar disorder during pregnancy and lactation. journal of Clinical Psychiatry, 59\(Suppl. 6), 57–64
   PubMedGoogle Scholar
• MAES, M., VERKERK, R., BONACCORSO, S., OMBELET, W., BOSMANS, E. & SCHARPE, S. (2002). Depressive and anxiety symptoms in the early puerperium are related to increased degradation of tryptophan into kynurenine, a phenomenon that is related to immune activation. Life Sciences, 71, 1837–1848
   PubMed Web of Science ®Google Scholar
• MANBER, R., ALLEN, J.J.B. & MORRIS, M.M. (2002). Alternative treatments for depression: empirical support and relevance to women. Journal of Clinical Psychiatry, 63, 628–640
   PubMed Web of Science ®Google Scholar
• MCELHATTON, P.R. (1994). The effects of benzodiazepine use during pregnancy and lactation. Reproductive Toxicology, 8, 461–475
   PubMed Web of Science ®Google Scholar
• McNEIL, T.F. & MALMQUIST-LARSSON, A. (1984). Women with non-organic psychosis: mental disturbance during pregnancy. Acta Psychiatrica Scandinavica, 70, 127–139
   PubMed Web of Science ®Google Scholar
• MHANNA, M.J., BENNET, J.B. & IZATT, S.D. (1997). Potential fluoxetine chloride (Prozac) toxicity in a newborn. Pediatrics, 100, 158–159
   PubMed Web of Science ®Google Scholar
• MILLER, L.J. (1994). Use of electroconvulsive therapy during pregnancy. Hospital & Community Psychiatry, 45, 444–450
   PubMedGoogle Scholar
• MOORE, K.L. & PERSAUD, T.V. (1998). The developing human: clinically oriented embryology, 6th edition. Philadelphia: WB Saunders Co
   Google Scholar
• NAHAS, Z., BOIINING, D.E., MOLLOY, M.A., OUSTZ, J.A., RISCH, S.C. & GEORGE, M.S. (1999). Safety and feasibility of repetitive transcranial magnetic stimulation in the treatment of anxious depression in pregnancy: a case report. Journal of Clinical Psychiatry, 60, 50–52
   PubMed Web of Science ®Google Scholar
• NEMETS, B., STAHL, Z. & BELMAKER, R.H. (2002). Addition of omega-3 fatty acid to maintenance medica-tion treatment for recurrent unipolar depressive disorder. American Journal of Psychiatry, 159, 477–479
   PubMed Web of Science ®Google Scholar
• NEWPORT, D.J., WILCOX, M.M. & STOWE, Z.N. (2001). Antidepressants during pregnancy and lactation: defining exposure and treatment issues. Seminars in Perinatology, 25, 177–190
   PubMed Web of Science ®Google Scholar
• NEZIROGLU, F., ANEMONE, R. & YARYURA-TOBIAS, J.A. (1992). Onset of obsessive-compulsive disorder in pregnancy. American Journal of Psychiatry, 149, 947–950
   PubMed Web of Science ®Google Scholar
• NILSSON, E., LICHTENSTEIN, P., CNATTINGIUS, S., MURRAY, R.M. & HULTMAN, C.M. (2002). Women with schizophrenia: pregnancy outcome and infant death among their offspring. Schizophrenia Research, 58, 221–229
   PubMed Web of Science ®Google Scholar
• NORTHCOTT, C.J. & STEIN, M.B. (1994). Panic disorder in pregnancy. Journal of Clinical Psychiatry, 55, 539–542
   PubMed Web of Science ®Google Scholar
• NULMAN, I., ROVET, J., STEWART, D.E., WOLPIN, J., GARDNER, H.A., THEIS, J.G., . & KOREN, G., for the Motherisk Program, Hospital for Sick Children and University of Toronto (1997). Neurodevelopment of children exposed in utero to antidepressant drugs. New England Journal of Medicine, 336, 258–262
   Google Scholar
• NULMAN, I., ROVET, J., STEWART, D.E., WOLPIN, J., PACE-ASCIAK, P., SHUHAIBER, S. & KOREN, G., for the Motherisk Program, Hospital for Sick Children and University of Toronto (2002). Child development following exposure to tricyclic antidepressants or fluo-xetine throughout fetal life: a prospective, controlled study. American journal of Psychiatry, /59(11), 1889–1895
   Google Scholar
• O‘CoNNoR, T.G., HERON, J.3 GOLDING, J.3 BEVERIDGE, M. & GLOVER, V. (2002). Maternal antenatal anxiety and children‘s behavioural/emotional problems at 4 years. Report from the Avon Longitudinal Study of Parents and Children. British Journal of Psychiatry, 180, 502–508
   Google Scholar
• O‘HARA, M.W., NEUNABER, D.J. & ZEKOSKI, E.M. (1984). Prospective study of postpartum depression: prevalence, course, and predictive factors. Journal of Abnormal Psychology, 93, 158–171
   Google Scholar
• OREN, D.A., WISNER, K.L., SPINFJJJ, M. EPPERSON, C.N., PEINOL, K.S., TERMAN, J.S. & TERMAN, M. (2002). An open trial of morning light therapy for treatment of antepartum depression. American Journal of Psychiatry, 159, 666–669
   PubMed Web of Science ®Google Scholar
• ORR, S.T. & MILLER, C.A. (1995). Maternal depressive symptoms and the risk of poor pregnancy outcome. Epidemiology Review, /7, 165–171
   Google Scholar
• PAJUL0, M., SAVONLAHTI, E., SOURANDER, A., FIELENIUS3 H. & PIHA, J. (2001). Antenatal depression, substance dependency and social support. Journal of Affective Disorders, 65, 9–17
   Google Scholar
• PARRY, B.L., CURRAN, M.L., STUENKEL, C.A., YOKIMOZO3 M., TAM, L., POWELL, K.A. & GILLIN, J.C. (2000). Can critically timed sleep deprivation be useful in pregnancy and postpartum depressions? Journal of Affective Disorders, 60, 201–212
   Google Scholar
• PASTUSZAK, A., SCHICK-BOSCHETTO, B. & ZUBER, C. (1993). Pregnancy outcome following first trimester exposure to fluoxetine (Prozac). Journal of the American Medical Association, 269, 2246–2248
   PubMed Web of Science ®Google Scholar
• PATTON, S.W., MISRI, S., CORRAL, M.R., PERRY, K.F. & KuAN, A.J. (2002). Antipsychotic medication during pregnancy and lactation in women with schizophrenia: evaluating the risk. Canadian Journal of Psychiatry, 47, 959–965
   PubMed Web of Science ®Google Scholar
• PINELLI, J.M3 SYMINGTON, AT, CUNNINGHAM, K.A. & PAEs, B.A. (2002). Case report and review of the perinatal implications of maternal lithium use. American Journal of Obstetrics & Gynecology, 187, 245–249
   PubMed Web of Science ®Google Scholar
• PLATT, J.E., FRIEDHOFF, A.J., BROMAN, S.H., BOND, R.N., LASKA, E. & LIN, S.P. (1988). Effects of prenatal exposure to neuroleptic drugs on children‘s growth. Neuropsychopharmacology, 1, 205–212
   PubMed Web of Science ®Google Scholar
• PURI, B.K., STEINER, R. & RICHARDSON, A.J. (1998). Sustained remission of positive and negative symptoms of schizophrenia following treatment with eicosapentae-noic acid. Archives in General Psychiatry, 55, 188–189
   PubMed Web of Science ®Google Scholar
• RAYBURN, W.F., CHRISTENSEN, H.D., & GONZALEZ, C.L. (2000). Effect of antenatal exposure to Saint John‘s wort (Hypericum) on neurobehavior of developing mice. American Journal of Obstetrics & Gynecology, 183, 1225–1231
   PubMed Web of Science ®Google Scholar
• RAYBURN, W.F., GONZALEZ, C.L., CHRISTENSEN, H.D. & STEWART, J.D. (2001). Effect of prenatally administered hypericum (St John‘s Wort) on growth and physical maturation of mouse offspring. American Journal of Obstetrics & Gynecology, 184, 191–195
   PubMed Web of Science ®Google Scholar
• REGISTRY OF CLOZARIe BABIES. (2002). Novartis Corp, East Hanover, NJ
   Google Scholar
• ROBINSON, L., WALKER, J.R. & ANDERSON, D. (1992). Cognitive-behavioral treatment of panic disorder during pregnancy and lactation. Canadian Journal of Psychiatry, 37, 623–626
   PubMed Web of Science ®Google Scholar
• RosA, F. (1994). Medicaid antidepressant pregnancy exposure outcome. Reproductive Toxicology, 8, 444–445
   Google Scholar
• SACKER, A., DONE, D.J. & CROW, T.J. (1996). Obstetric complications in children born to parents with schizo-phrenia: a meta-analysis of case-control studies. Psychological Medicine, 26, 279–287
   PubMed Web of Science ®Google Scholar
• SAFRA, M.J. & OAKLEY, G.P. JR. (1975). Association between cleft lip with or without cleft palate and prenatal exposure to diazepam. Lancet, 2, 478–480
   PubMed Web of Science ®Google Scholar
• SAKS, B.R. (2001). Mirtazapine: treatment of depression, anxiety, and hyperemesis gravidarum in the pregnant patient: a report of 7 cases. Archives of Women‘s Mental Health, 4, 165–170
   Google Scholar
• SANDMAN, C.A., WADHWA, P.D., DUNKEL-SCHETTER, C., CHICZ-DEMET, A., BELMAN, J., PORTO, M., MURATA, Y., GARITE, T.J. & CIUNELLA, F.M. (1994). Psychobiological influences of stress and HPA regulation on the human fetus and infant birth outcomes. Annals of the NY Academy of Science, 739, 198–210
   PubMed Web of Science ®Google Scholar
• ScHou, M. (1976). What happened to the lithium babies? A follow-up study of children born without malforma-tions. Acta Psychiatrica Scandinavica, 54, 193–197
   PubMed Web of Science ®Google Scholar
• SCOLNIK, D., NULMAN, I. & RUVET, J. (1994). Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy. journal of the American Medical Association, 271, 767–770
   PubMed Web of Science ®Google Scholar
• SHEAR, M.K. & MAMMEN, 0. (1995). Anxiety disorders in pregnant and postpartum women. Psychopharmacological Bulletin, 31, 693–703
   Google Scholar
• SIINIDER, S.M. & LEVINSON, G. (1993). Anesthesia for Obstetrics, 3rd edition. Baltimore: William & Wilkins
   Google Scholar
• SIMINOFF, L.A. & FETTING, J.H. (1989). Effects of outcome framing on treatment decisions in the real world: impact of framing on adjuvant breast cancer decisions. Medical Decision Making, 9, 262–271
   PubMed Web of Science ®Google Scholar
• SIMON, G.E., CUNNINGHAM, M.L. & DAVIS, R.L. (2002). Outcomes of prenatal antidepressant exposure. American Journal of Psychiatry, /59(12), 2055–2061
   Google Scholar
• SLovic, P. (1987). Perception of risk. Science, 36, 280–285
   Google Scholar
• SPINELLI, M.G. (1997). Interpersonal psychotherapy for depressed antepartum women: a pilot study. American Journal of Psychiatry, 154, 1028–1030
   PubMed Web of Science ®Google Scholar
• ST CLAIR, S.M. & SCHIRMER, R.G. (1992). First-trimester exposure to alprazolam. Obstetrics & Gynecology, 80, 843–846
   PubMed Web of Science ®Google Scholar
• STEER, R.A., SCROLL, T.O., HEDIGER, M.L. & FISCHER, R.L. (1992). Self-reported depression and negative pregnancy outcomes. Journal of Clinical Epidemiology, 45, 1093–1099
   PubMed Web of Science ®Google Scholar
• STOLL, A.L., SEVERUS, E., FREEMAN, M.P., RUETER, S., ZBOYAN, H.A., DIAMOND, E., CRESS, K.K. & MARANGELL, L.B. (1999). Omega-3 fatty acids in bipolar disorder: a double-blind placebo-controlled trial. Archives in General Psychiatry, 56, 407–412
   PubMed Web of Science ®Google Scholar
• STONER, S.C., SOMMI, R.W. JR. & MARREN, P.A. (1997). Clozapine use in two full-term pregnancies (letter). Journal of Clinical Psychiatry, 58, 364–365
   Google Scholar
• STOTT, D.H. (1973). Follow-up study from birth of the effects of prenatal stresses. Developmental Medicine & Child Neurology, 15, 770–787
   PubMed Web of Science ®Google Scholar
• Su, K., SHEN, W.W. & HUANG, S. (2001). Omega-3 fatty acids as a psychotherapeutic agent for a pregnant schizophrenic patient. European Neuropsychophar-macology, 11, 295–299
   PubMed Web of Science ®Google Scholar
• TERMAN, M., TERMAN, J.S. & Ross, D.C. (1998). A controlled trial of timed bright light and negative air ionization for treatment of winter depression. Archives in General Psychiatry, 55, 875–882
   PubMed Web of Science ®Google Scholar
• VIGGEDAL, G., HAGBERG, B.S., LAEGREID, L. & ARONSSON, M. (1993). Mental development in late infancy after prenatal exposure to benzodiazepines-a prospective study. Journal of Child Psychology & Psychiatry, 34, 295–305
   PubMed Web of Science ®Google Scholar
• VIGUER A. C .3 COHEN, L.S., BALDESSARINI, R.J. & NONACS, R. (2002a). Managing bipolar disorder during pregnancy: weighing the risks and benefits. Canadian Journal of Psychiatry, 47, 426–436
   Google Scholar
• VIGUERA, A.C., COHEN, L.S., BOUFFARD, S., WHITFIELD, T.H. & BALDESSARINI, R.J. (2002b). Reproductive decisions by women with bipolar disorder after pre-pregnancy psychiatric consultation. American Journal of Psychiatry, 159(12), 2102–2104
   PubMed Web of Science ®Google Scholar
• VIGUERA, A.C., NONACS, R., COHEN, L.S., TONDO, L., MURRAY, A. & BALDESSARINI, R.J. (2000). Risk of recurrence of bipolar disorder in pregnant and non-pregnant women after discontinuing lithium mainte-nance. American Journal of Psychiatry, 157, 179–184
   PubMed Web of Science ®Google Scholar
• VIGUERA, A.C., MCCARTHY, C., WHITFIELD, T.H., POITRA, J.R., BEKKEN, K. & SHERMAN, J. (2001). Neurobehavioral outcome following lithium exposure: what happens to lithium babies. New Orleans: American Psychiatric Association
   Google Scholar
• VIILEPONTEAUX, V.A., LYDIARD, R.B., LARAIA, M.T., STUART, G.W. & BALLENGER, J. C . (1992). The effects of pregnancy on pre-existing panic disorder. Journal of Clinical Psychiatry, 53, 201–203
   PubMed Web of Science ®Google Scholar
• VITIELLO, B. (1998). Pediatric psychopharmacology and the interaction between drugs and the developing brain. Canadian Journal of Psychiatry, 43, 582–584
   PubMed Web of Science ®Google Scholar
• WADHWA, P.D., SANDMAN, C.A., PORTO, M., DUNKEL-SCHETTER, C. & GAIUTE, T.J. (1993). The association between prenatal stress and infant birth weight and gestational age at birth: a prospective investigation. American Journal of Obstetrics & Gynecology, /69, 858–865
   Google Scholar
• WALDMAN, M.D. & SAFFERMAN, A.Z. (1993). Pregnancy and clozapine. American Journal of Psychiatry, 150, 168–169
   PubMed Web of Science ®Google Scholar
• WARE, M.R. & DWANE, C.L. (1990). Imipramine treat-ment of panic disorder during pregnancy (letter). Journal of Clinical Psychiatry, 51, 482–484
   PubMed Web of Science ®Google Scholar
• WEBSTER, P.A. (1973). Withdrawal symptoms in neonates associated with maternal antidepressant therapy. Lancet, 2, 318–319
   PubMed Web of Science ®Google Scholar
• WEINSTEIN, M.R. & GOLDFIELD, M. (1975). Cardiovascular malformations with lithium use during pregnancy. American Journal of Psychiatry, 132, 529–531
   PubMed Web of Science ®Google Scholar
• WEISBERG, R.B. & PAQUETTE, J.A. (2002). Screening and treatment of anxiety disorders in pregnant women. Women‘s Health Issues, 12, 32–36
   PubMed Web of Science ®Google Scholar
• WILLIAMS, K.E. & KORAN, L.M. (1997). Obsessive-compulsive disorder in pregnancy, the puerperium, and the premenstruum. Journal of Clinical Psychiatry, 58(7), 330–334
   PubMed Web of Science ®Google Scholar
• WILSON, J.G. (1977). Current status of teratology: general principles and mechanisms derived from animal studies. In: J.G. WILSON & F.C. FRASER (Eds), Handbook of Teratology, General Principles and Etiology (pp. 47–74). New York: Plenum Press
   Google Scholar
• WISNER, K.L., GELENBERG, A.J., LEONARD, H., ZARIN, D. & FRANK, E. (1999). Pharmacologic treatment of depres-sion during pregnancy. Journal of the American Medical Association, 282, 1264–1269
   PubMed Web of Science ®Google Scholar
• WISNER, K.L., PEINDL, K.S. & HANUSA, B.H. (1996). Effects of childbearing on the natural history of panic disorder with comorbid mood disorder. Journal of Affective Disorders, 4/(3), 173–180
   Google Scholar
• WISNER, K.L., PEINDL, K. S. & PEREL, J.M. (2002). Verapamil treatment for women with bipolar disorder. Biological Psychiatry, 51, 745–752
   Google Scholar
• WISNER, K.L. & PEREL, J.M. (1988). Psychopharmacologic agents and electroconvulsive therapy during pregnancy and the puerperium. In: R.L. COHEN (Ed), Psychiatric Consultation in Childbirth Settings (pp. 165–206). New York: Plenum
   Google Scholar
• WISNER, K.L., PEREL, J.M. & WHEELER, S.B. (1993). Tricyclic dose requirements across pregnancy. American Journal of Psychiatry, 150, 1541–1542
   PubMed Web of Science ®Google Scholar
• WISNER, K.L., ZARIN, D.A., HOLMBOE, E.S., APPELBAUM, P.S., GELENBERG, A.J., LEONARD, H.L. & FRANK, E. (2000). Risk-benefit decision making for treatment of depression during pregnancy. American Journal of Psychiatry, 157(12), 1933–1940
   PubMed Web of Science ®Google Scholar
• Wu, J., VIGUERA, A., RILEY, L., COHEN, L. & ECKER, J. (2002). Mood disturbance in pregnancy and the mode of delivery. American Journal of Obstetrics & Gynecology, /87(4), 864–867
   Google Scholar
• YERBY, M.S. (1987). Problems and management of the pregnant woman with epilepsy. Epilepsia, 28\(Suppl. 3), 29–36
   Google Scholar
• YOUNG, S.A., CAMPBELL, N. & HARPER, A. (2002). Depression in women of reproductive age. Considera-tions in selecting safe, effective therapy. Postgraduate Medicine, 112(3), 45–50
   PubMed Web of Science ®Google Scholar
• ZANAIUNI, M.C. & FRANKENBURG, F.R. (2003). Omega-3 fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study. American Journal of Psychiatry, 160, 167–169
   PubMed Web of Science ®Google Scholar
• ZUCKERMAN, B., AMAR03 H., BAUCHNER, H. & CABRAL, H. (1989). Depressive symptoms during pregnancy: rela-tionship to poor health behaviors. American Journal of Obstetrics & Gynecology, 160, 1107–1111
   Google Scholar